Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr;91(5):1028-1035.
doi: 10.1038/s41390-021-01465-y. Epub 2021 Mar 25.

Tackling healthcare access barriers for individuals with autism from diagnosis to adulthood

Affiliations
Review

Tackling healthcare access barriers for individuals with autism from diagnosis to adulthood

Natasha Malik-Soni et al. Pediatr Res. 2022 Apr.

Abstract

Most individuals with autism spectrum disorder (ASD)-a complex, life-long developmental disorder-do not have access to the care required to address their diverse health needs. Here, we review: (1) common barriers to healthcare access (shortage/cost of services; physician awareness; stigma); (2) barriers encountered primarily during childhood (limited screening/diagnosis; unclear referral pathways), transition to adulthood (insufficient healthcare transition services; suboptimal physician awareness of healthcare needs) and adulthood (shortage of services/limited insurance; communication difficulties with physicians; limited awareness of healthcare needs of aging adults); and (3) advances in research/program development for better healthcare access. A robust understanding of barriers to accessing healthcare across the lifespan of autistic individuals is critical to ensuring the best use of healthcare resources to improve social, physical, and mental health outcomes. Stakeholders must strengthen healthcare service provision by coming together to: better understand healthcare needs of underserved populations; strengthen medical training on care of autistic individuals; increase public awareness of ASD; promote research into/uptake of tools for ASD screening, diagnosis, and treatment; understand specific healthcare needs of autistic individuals in lower resource countries; and conduct longitudinal studies to understand the lifetime health, social, and economic impacts of ASD and enable the evaluation of novel approaches to increasing healthcare access. IMPACT: Despite the growing body of evidence, our understanding of barriers to healthcare encountered by individuals with ASD remains limited, particularly beyond childhood and in lower resource countries. We describe current and emerging barriers to healthcare access encountered by individuals with ASD across the lifespan. We recommend that stakeholders develop evidence-informed policies, programs, and technologies that address barriers to healthcare access for individuals with ASD and consider broad, equitable implementation to maximize impact.

PubMed Disclaimer

Conflict of interest statement

T.W.F. has received funding or research support from, acted as a consultant to, received travel support from, and/or received a speaker’s honorarium from Quadrant Biosciences, Impel NeuroPharma, F. Hoffmann-La Roche AG Pharmaceuticals, the Cole Family Research Fund, Simons Foundation, Ingalls Foundation, Forest Laboratories, Ecoeos, IntegraGen, Kugona LLC, Shire Development, Bristol-Myers Squibb, Roche Pharma, National Institutes of Health, and the Brain and Behavior Research Foundation and has an investor stake in Autism EYES LLC. J.F. has received research support from Policlinica Gipuzkoa Foundation (PGF), Servier, and AIMS-2 Trials/Project ID 777394. He has received partial support for professional meetings attendance from PGF, ESCAP & AACAP.

Figures

Fig. 1
Fig. 1. Barriers to healthcare encountered by individuals with autism spectrum disorder (ASD).
Summary of unique barriers to healthcare experienced by autistic individuals during distinct life stages (top panel) and common barriers to healthcare encountered throughout the lifespan (bottom panel).

Comment in

References

    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn (American Psychiatric Association, 2013).
    1. Elsabbagh M, et al. Global prevalence of autism and other pervasive developmental disorders. Autism Res. 2012;5:160–179. doi: 10.1002/aur.239. - DOI - PMC - PubMed
    1. Buescher AVS, Cidav Z, Knapp M, Mandell DS. Costs of autism spectrum disorders in the United Kingdom and the United States. JAMA Pediatr. 2014;168:721–728. doi: 10.1001/jamapediatrics.2014.210. - DOI - PubMed
    1. Knapp M, Romeo R, Beecham J. Economic cost of autism in the UK. Autism. 2009;13:317–336. doi: 10.1177/1362361309104246. - DOI - PubMed
    1. Markowitz LA, et al. Development and psychometric evaluation of a psychosocial quality-of-life questionnaire for individuals with autism and related developmental disorders. Autism. 2016;20:832–844. doi: 10.1177/1362361315611382. - DOI - PMC - PubMed

Publication types